首页 > 最新文献

CVIR Endovascular最新文献

英文 中文
The RAVI registry: prospective, multicenter study of radial access in embolization procedures - 30 days follow up. RAVI 登记:栓塞手术中桡动脉入路的前瞻性多中心研究 - 30 天随访。
IF 1.2 Pub Date : 2024-01-30 DOI: 10.1186/s42155-023-00415-5
Marcelo Guimaraes, Aaron Fischman, Hyeon Yu, Jordan Tasse, Jessica Stewart, Keith Pereira

Background: There is a lack of registry studies about transradial access (TRA) outcomes. This prospective registry evaluated the TRA and procedure outcomes of visceral embolizations performed via TRA with 30-day follow-up.

Material & methods: Prospective, multicenter registry included uterine fibroids (UFE), prostate artery (PAE), liver tumors (LT), and other hypervascular tumors (OHT) embolization performed in six US hospitals. Between February 2020 and January 2022, 99 patients underwent one radial artery visceral intervention (RAVI); 70 had UFE (70.7%), 16 PAE (16.2%), 7 LT (7.1%), and 6 OHT (6.1%). The mean age was 50.1 (±11.1) years, and 74/99 (74.7%) were females. The primary safety endpoints included hand ischemia, stroke, and death. Procedural success was defined as completing the intended procedure via radial artery (RA) access. Technical success was defined as the successful delivery of HydroPearl™ microspheres and complete embolization of the target vessel.

Results: Procedural and technical successes were 100% and 97%, respectively. There was no stroke, hand ischemia, radial-to-femoral conversion, access-related serious adverse events, or clinically evident radial artery occlusion at 30 days. There were two deaths: one respiratory failure and one progression of liver disease. Minor RA-related adverse event included arterial spasm, hematoma, and post-procedure discomfort.

Conclusion: This prospective, multicenter, open-label registry confirmed the high safety profile and effectiveness of radial access in UFE, PAE, LT, and OHT embolization procedures without stroke, hand ischemia, or access-related serious adverse events at 30-day follow-up.

背景:目前缺乏有关经桡动脉入路(TRA)结果的登记研究。这项前瞻性登记研究评估了经桡动脉入路栓塞(TRA)和经桡动脉入路栓塞(TRA)内脏栓塞的手术效果,并进行了30天的随访:前瞻性多中心登记包括在美国六家医院进行的子宫肌瘤(UFE)、前列腺动脉(PAE)、肝脏肿瘤(LT)和其他高血管肿瘤(OHT)栓塞术。2020年2月至2022年1月期间,99名患者接受了一次桡动脉内脏介入治疗(RAVI);其中70人患有UFE(70.7%),16人患有PAE(16.2%),7人患有LT(7.1%),6人患有OHT(6.1%)。平均年龄为 50.1 (±11.1) 岁,74/99(74.7%)人为女性。主要安全性终点包括手部缺血、中风和死亡。手术成功定义为通过桡动脉(RA)入路完成预定手术。技术成功是指成功输送 HydroPearl™ 微球并完全栓塞靶血管:手术成功率和技术成功率分别为100%和97%。30 天内没有发生中风、手部缺血、桡动脉到股动脉的转换、与介入相关的严重不良事件或临床上明显的桡动脉闭塞。有两例死亡:一例呼吸衰竭,一例肝病恶化。与 RA 相关的轻微不良事件包括动脉痉挛、血肿和术后不适:这项前瞻性、多中心、开放标签登记证实了桡动脉入路在 UFE、PAE、LT 和 OHT 栓塞手术中的高度安全性和有效性,30 天随访时未发生中风、手部缺血或与入路相关的严重不良事件。
{"title":"The RAVI registry: prospective, multicenter study of radial access in embolization procedures - 30 days follow up.","authors":"Marcelo Guimaraes, Aaron Fischman, Hyeon Yu, Jordan Tasse, Jessica Stewart, Keith Pereira","doi":"10.1186/s42155-023-00415-5","DOIUrl":"10.1186/s42155-023-00415-5","url":null,"abstract":"<p><strong>Background: </strong>There is a lack of registry studies about transradial access (TRA) outcomes. This prospective registry evaluated the TRA and procedure outcomes of visceral embolizations performed via TRA with 30-day follow-up.</p><p><strong>Material & methods: </strong>Prospective, multicenter registry included uterine fibroids (UFE), prostate artery (PAE), liver tumors (LT), and other hypervascular tumors (OHT) embolization performed in six US hospitals. Between February 2020 and January 2022, 99 patients underwent one radial artery visceral intervention (RAVI); 70 had UFE (70.7%), 16 PAE (16.2%), 7 LT (7.1%), and 6 OHT (6.1%). The mean age was 50.1 (±11.1) years, and 74/99 (74.7%) were females. The primary safety endpoints included hand ischemia, stroke, and death. Procedural success was defined as completing the intended procedure via radial artery (RA) access. Technical success was defined as the successful delivery of HydroPearl™ microspheres and complete embolization of the target vessel.</p><p><strong>Results: </strong>Procedural and technical successes were 100% and 97%, respectively. There was no stroke, hand ischemia, radial-to-femoral conversion, access-related serious adverse events, or clinically evident radial artery occlusion at 30 days. There were two deaths: one respiratory failure and one progression of liver disease. Minor RA-related adverse event included arterial spasm, hematoma, and post-procedure discomfort.</p><p><strong>Conclusion: </strong>This prospective, multicenter, open-label registry confirmed the high safety profile and effectiveness of radial access in UFE, PAE, LT, and OHT embolization procedures without stroke, hand ischemia, or access-related serious adverse events at 30-day follow-up.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"15"},"PeriodicalIF":1.2,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and feasibility study of a novel robotic system in an in vivo porcine vascular model. 新型机器人系统在猪体内血管模型中的安全性和可行性研究。
IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-27 DOI: 10.1186/s42155-024-00425-x
Ornella Moschovaki-Zeiger, Nikolaos-Achilleas Arkoudis, Stavros Spiliopoulos

Purpose: The goal of this preclinical study is to assess the functionality, technical feasibility, and safety of a new vascular robotic LIBERTYR 3 System, in the microcatheterization of vascular targets using a range of guidewires and microcatheters.

Material and methods: An anesthetized pig served as an arterial model for the robotic device (LIBERTYR3; Microbot Medical Ltd, Yoqneam, IL). The primary efficacy endpoint was the evaluation of its capability to selectively catheterize predetermined distal arterial branches in the liver, kidneys, and mesenteric arteries (technical success), under fluoroscopy guidance. The primary safety endpoint was the occurrence of angiographic acute catheterization-related complications (dissection, thrombosis, embolism, perforation). The catheterizations were conducted by two interventional radiologists that present different work experience in endovascular procedures (18 and 2 years respectively), using a variety of microcatheters and wires. Various procedural parameters such as functionality, practicality, ease of use, and time required for selective catheterization, were evaluated, and recorded.

Results: All pre-determined arteries were successfully selectively catheterized (100% technical success), by both operators. No angiographic acute complications occurred. The microcatheters and wires were manipulated using the remote portable console in an effortless manner that maintained a high level of accuracy. Mean time for selective catheterization was 131 ± 82 s. The robot's conversion function to manual operation was successfully demonstrated.

Conclusion: Robotic navigation and catheterization of selected target arteries were accomplished without observable vascular damage, suggesting that the LIBERTYR 3 robotic system is a reliable and safe tool for robotic-assisted endovascular navigation. Further experimental studies are required to evaluate safety and efficacy prior to introduction into clinical practice.

目的:本临床前研究的目的是评估新型血管机器人 LIBERTYR 3 系统在使用一系列导丝和微导管对血管靶点进行微导管治疗时的功能性、技术可行性和安全性:一只麻醉猪作为机器人设备(LIBERTYR3;Microbot Medical Ltd,伊利诺伊州尤克纳姆)的动脉模型。主要疗效终点是评估其在透视引导下选择性导管肝脏、肾脏和肠系膜动脉的预定远端动脉分支的能力(技术成功)。主要安全终点是发生血管造影急性导管相关并发症(夹层、血栓、栓塞、穿孔)。导管手术由两名介入放射科医生进行,他们在血管内手术方面的工作经验各不相同(分别为 18 年和 2 年),使用了各种微导管和导线。评估并记录了各种程序参数,如功能性、实用性、易用性和选择性导管插入所需的时间:结果:两名操作员都成功地对所有预定动脉进行了选择性导管插入(技术成功率 100%)。没有出现血管造影急性并发症。使用遥控便携式控制台操作微导管和导线毫不费力,并保持了高度的准确性。选择性导管插入的平均时间为 131 ± 82 秒:结论:机器人导航和选定靶动脉导管术均已完成,未发现明显的血管损伤,这表明 LIBERTYR 3 机器人系统是机器人辅助血管内导航的可靠、安全工具。在将其引入临床实践之前,还需要进一步的实验研究来评估其安全性和有效性。
{"title":"Safety and feasibility study of a novel robotic system in an in vivo porcine vascular model.","authors":"Ornella Moschovaki-Zeiger, Nikolaos-Achilleas Arkoudis, Stavros Spiliopoulos","doi":"10.1186/s42155-024-00425-x","DOIUrl":"10.1186/s42155-024-00425-x","url":null,"abstract":"<p><strong>Purpose: </strong>The goal of this preclinical study is to assess the functionality, technical feasibility, and safety of a new vascular robotic LIBERTY<sup>R</sup> 3 System, in the microcatheterization of vascular targets using a range of guidewires and microcatheters.</p><p><strong>Material and methods: </strong>An anesthetized pig served as an arterial model for the robotic device (LIBERTY<sup>R</sup>3; Microbot Medical Ltd, Yoqneam, IL). The primary efficacy endpoint was the evaluation of its capability to selectively catheterize predetermined distal arterial branches in the liver, kidneys, and mesenteric arteries (technical success), under fluoroscopy guidance. The primary safety endpoint was the occurrence of angiographic acute catheterization-related complications (dissection, thrombosis, embolism, perforation). The catheterizations were conducted by two interventional radiologists that present different work experience in endovascular procedures (18 and 2 years respectively), using a variety of microcatheters and wires. Various procedural parameters such as functionality, practicality, ease of use, and time required for selective catheterization, were evaluated, and recorded.</p><p><strong>Results: </strong>All pre-determined arteries were successfully selectively catheterized (100% technical success), by both operators. No angiographic acute complications occurred. The microcatheters and wires were manipulated using the remote portable console in an effortless manner that maintained a high level of accuracy. Mean time for selective catheterization was 131 ± 82 s. The robot's conversion function to manual operation was successfully demonstrated.</p><p><strong>Conclusion: </strong>Robotic navigation and catheterization of selected target arteries were accomplished without observable vascular damage, suggesting that the LIBERTY<sup>R</sup> 3 robotic system is a reliable and safe tool for robotic-assisted endovascular navigation. Further experimental studies are required to evaluate safety and efficacy prior to introduction into clinical practice.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"14"},"PeriodicalIF":1.2,"publicationDate":"2024-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10821852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139572104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cephalic arch stenosis: an analysis of outcome by type of first intervention. 头弓狭窄:按首次干预类型进行的结果分析。
IF 1.2 Pub Date : 2024-01-19 DOI: 10.1186/s42155-023-00424-4
Umberto Pisano, Karen Stevenson, Ram Kasthuri, David Kingsmore

Background: Cephalic arch stenoses (CAS) occur in near 70% of elbow arteriovenous fistulas. Percutaneous transluminal angioplasty (PTA) remains first-line treatment despite documented stent-grafts (SG) efficacy. The study aim is to report long-term outcomes based on initial treatment of CAS.

Methods: Retrospective review of 12-year data in single tertiary centre. Outcomes included technical success, rupture rate, primary patency (PP), dialysis performance; categorical variables assessed via χ2 or Fisher's; nonparametric tests used for skewed data. Kaplan-Meier analysis used for PP and cumulative patency. Cox proportional hazard regression model to assess explanatory variables in PP.

Results: One hundred one brachio- and radiocephalic fistulas with CAS were included. SG as first intervention had higher success than PTA (85% vs 61%, p = 0.003). Rupture occurred in 9/85 (10.6%) PTA vs 0% in SG (p = 0.046). In a subgroup with poor urea reduction rate (URR), both PTA and SG improved dialysis performance post-intervention (p = 0.002). SG demonstrated better PP than PTA (79,73,60% patency at 3, 6, 9 months; versus 71,51,47%; p = 0.195) and cumulative patency (73,61,61% at 1, 2, 3 years; versus 60,34,26%; p < 0.001). Of the variables analyzed, technical success of PTA was the only discriminating factor (coeff.-1.01; RR 35%, p = 0.035). Accesses that underwent secondary stenting performed better than primarily stented CAS (p = 0.01).

Conclusions: SG superiority is confirmed in CAS, particularly when angioplasty is unsuccessful. While PTA has short-lived benefits, it can improve dialysis performance. Other than higher success rate, primary CAS stenting did not have advantages compared to post-PTA stenting in our study. Other factors related to inflow, outflow, conduit characteristics are presumed to be involved in access longevity.

背景:近 70% 的肘动静脉瘘都存在头弓狭窄 (CAS)。经皮腔内血管成形术(PTA)仍是一线治疗方法,尽管支架移植物(SG)的疗效已得到证实。本研究旨在报告基于 CAS 初始治疗的长期疗效:方法:对单个三级中心 12 年的数据进行回顾性分析。结果包括技术成功率、破裂率、初次通畅率(PP)、透析效果;分类变量通过χ2或费雪氏进行评估;对偏斜数据采用非参数检验。PP 和累积通畅率采用 Kaplan-Meier 分析。Cox比例危险回归模型用于评估PP的解释变量:结果:共纳入了 1001 例使用 CAS 的肱瘘和射血瘘。SG 作为首次介入治疗的成功率高于 PTA(85% vs 61%,P = 0.003)。9/85(10.6%)例 PTA 发生破裂,而 SG 为 0%(P = 0.046)。在尿素还原率(URR)较差的亚组中,PTA 和 SG 均改善了干预后的透析效果(p = 0.002)。SG 的 PP 值(3、6、9 个月的通畅率分别为 79、73、60%;71、51、47%;p = 0.195)和累积通畅率(1、2、3 年的通畅率分别为 73、61、61%;60、34、26%;p)均优于 PTA:SG在CAS中的优越性得到了证实,尤其是在血管成形术不成功的情况下。虽然 PTA 的获益时间较短,但可以改善透析效果。在我们的研究中,除了更高的成功率外,CAS初次支架植入术与PTA后支架植入术相比并无优势。据推测,其他与流入、流出和导管特征有关的因素也会影响通路的寿命。
{"title":"Cephalic arch stenosis: an analysis of outcome by type of first intervention.","authors":"Umberto Pisano, Karen Stevenson, Ram Kasthuri, David Kingsmore","doi":"10.1186/s42155-023-00424-4","DOIUrl":"10.1186/s42155-023-00424-4","url":null,"abstract":"<p><strong>Background: </strong>Cephalic arch stenoses (CAS) occur in near 70% of elbow arteriovenous fistulas. Percutaneous transluminal angioplasty (PTA) remains first-line treatment despite documented stent-grafts (SG) efficacy. The study aim is to report long-term outcomes based on initial treatment of CAS.</p><p><strong>Methods: </strong>Retrospective review of 12-year data in single tertiary centre. Outcomes included technical success, rupture rate, primary patency (PP), dialysis performance; categorical variables assessed via χ<sup>2</sup> or Fisher's; nonparametric tests used for skewed data. Kaplan-Meier analysis used for PP and cumulative patency. Cox proportional hazard regression model to assess explanatory variables in PP.</p><p><strong>Results: </strong>One hundred one brachio- and radiocephalic fistulas with CAS were included. SG as first intervention had higher success than PTA (85% vs 61%, p = 0.003). Rupture occurred in 9/85 (10.6%) PTA vs 0% in SG (p = 0.046). In a subgroup with poor urea reduction rate (URR), both PTA and SG improved dialysis performance post-intervention (p = 0.002). SG demonstrated better PP than PTA (79,73,60% patency at 3, 6, 9 months; versus 71,51,47%; p = 0.195) and cumulative patency (73,61,61% at 1, 2, 3 years; versus 60,34,26%; p < 0.001). Of the variables analyzed, technical success of PTA was the only discriminating factor (coeff.-1.01; RR 35%, p = 0.035). Accesses that underwent secondary stenting performed better than primarily stented CAS (p = 0.01).</p><p><strong>Conclusions: </strong>SG superiority is confirmed in CAS, particularly when angioplasty is unsuccessful. While PTA has short-lived benefits, it can improve dialysis performance. Other than higher success rate, primary CAS stenting did not have advantages compared to post-PTA stenting in our study. Other factors related to inflow, outflow, conduit characteristics are presumed to be involved in access longevity.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"13"},"PeriodicalIF":1.2,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139492932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing your practice: debriefing in interventional radiology. 加强实践:介入放射学中的情况汇报。
IF 1.2 Pub Date : 2024-01-16 DOI: 10.1186/s42155-023-00412-8
Kara Fitzgerald, Jesse Knight, Karim Valji

Learning objectives: Review the history of debriefing and provide an Interventional Radiologist (IR) specific framework for leading an effective debrief.

Background: A debrief is often regarded as a meeting with persons who were involved in a stressful, traumatic and/or emotionally challenging situation to review processes, communicate concerns or gather feedback. The goals of these sessions can be for learning/quality improvement (QI) or psychological/emotional support, or a mix of both. Debriefing after tough situations has become a standard tool of many medical specialties, such as surgery, critical care and emergency medicine, with specialty specific literature available. However, there is a paucity of Interventional Radiology specific literature available for debriefing techniques.

Clinical findings/procedure details: We will review the history and types of debriefing and why a debrief could be considered. We will provide a framework for leading a successful debrief in Interventional Radiology.

Conclusion: Debriefing can be a useful tool for learning and QI as well as psychological or emotional support after a challenging or tough situation. Debriefing can address multiple variables and can stylistically be tailored to suit specific needs. IRs have an opportunity to take a leadership role in debriefing, providing comfort and quality improvement through communication and support.

学习目标:背景:回顾汇报的历史,为介入放射科医生(IR)提供领导有效汇报的具体框架:背景: 汇报通常被认为是与涉及压力、创伤和/或情绪挑战情况的人员举行会议,以回顾过程、传达关切或收集反馈。这些会议的目的可以是学习/质量改进(QI)或心理/情感支持,或两者兼而有之。艰难情况后的汇报已成为外科、重症监护和急诊医学等许多医学专科的标准工具,并有专科文献可查。然而,介入放射学方面关于汇报技巧的专门文献却很少:我们将回顾汇报的历史和类型,以及考虑进行汇报的原因。我们将为介入放射学中的成功汇报提供一个框架:汇报可以成为学习和质量改进的有用工具,也可以在遇到挑战或艰难情况后提供心理或情感支持。汇报可以处理多种变量,在风格上也可以根据具体需要进行调整。内部审计员有机会在汇报中发挥领导作用,通过沟通和支持提供安慰和质量改进。
{"title":"Enhancing your practice: debriefing in interventional radiology.","authors":"Kara Fitzgerald, Jesse Knight, Karim Valji","doi":"10.1186/s42155-023-00412-8","DOIUrl":"10.1186/s42155-023-00412-8","url":null,"abstract":"<p><strong>Learning objectives: </strong>Review the history of debriefing and provide an Interventional Radiologist (IR) specific framework for leading an effective debrief.</p><p><strong>Background: </strong>A debrief is often regarded as a meeting with persons who were involved in a stressful, traumatic and/or emotionally challenging situation to review processes, communicate concerns or gather feedback. The goals of these sessions can be for learning/quality improvement (QI) or psychological/emotional support, or a mix of both. Debriefing after tough situations has become a standard tool of many medical specialties, such as surgery, critical care and emergency medicine, with specialty specific literature available. However, there is a paucity of Interventional Radiology specific literature available for debriefing techniques.</p><p><strong>Clinical findings/procedure details: </strong>We will review the history and types of debriefing and why a debrief could be considered. We will provide a framework for leading a successful debrief in Interventional Radiology.</p><p><strong>Conclusion: </strong>Debriefing can be a useful tool for learning and QI as well as psychological or emotional support after a challenging or tough situation. Debriefing can address multiple variables and can stylistically be tailored to suit specific needs. IRs have an opportunity to take a leadership role in debriefing, providing comfort and quality improvement through communication and support.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"12"},"PeriodicalIF":1.2,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139473097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudoaneurysms embolization with glue via percutaneous direct puncture: a multicenter experience on 54 patients. 通过经皮直接穿刺用胶水栓塞假性动脉瘤:54 例患者的多中心经验。
IF 1.2 Pub Date : 2024-01-15 DOI: 10.1186/s42155-024-00426-w
Francesco Giurazza, Annamaria Ierardi, Paolo Marra, Pierleone Lucatelli, Fabio Corvino, Francesco Pane, Sandro Sironi, Gianpaolo Carrafiello, Romaric Loffroy, Raffaella Niola

Background: This retrospective multicentric study aims to report on technical safety and effectiveness of pseudoaneurysms embolization with glue (N-butyl cyanoacrylate) adopting a percutaneous direct puncture approach.

Results: Fifty-four patients data were collected from five centers. All patients at the time of treatment presented with unruptured PAs and were hemodynamically stable. True aneurysms and lesions treated with embolics other than glue were excluded. Pseudoaneurysms diagnosis was based on CT and anamnestic data; initial investigation with digital-subtracted arteriography was acquired in all cases; then, percutaneous embolizations were performed in the angio-suite (ultrasound, fluoroscopy, ConeBeam CT guidance) or in CT. Technical success was considered as complete pseudoaneurysm embolization at final imaging with sole percutaneous strategy, without need for additional endovascular embolization. Clinical success was intended as pseudoaneurysm resolution within one week follow-up with stabilization or restored clinical conditions. Pseudoaneurysms origins were traumatic (57.4%), inflammatory (24.1%) or spontaneous (18.5%); 39 patients (72.2%) were symptomatic, presenting with pain and/or pulsatile mass. Mean lesions diameter was 19.3 mm (range: 7-30); pseudoaneurysms were located in abdomen (48.1%), limbs (42.6%) and thorax (9.3%). Coagulation function was impaired in 16.6% and 48.1% was under antiplatelets/anticoagulation therapy. In 16.6% the percutaneous approach followed previous treatments failure. The image-guidance modality for percutaneous puncture was most often ultrasound combined with fluoroscopy (38%). Clinical success was obtained in all patients while technical success occurred in 94.4% because 3 patients required an additional endovascular embolization. Complications were registered in 14.8%, all of low grade without clinical sequelae neither prolonged recovery (7 non target embolizations, 1 post-embolization syndrome).

Conclusions: In this study, pseudoaneurysms embolization with glue via percutaneous direct puncture was safe and effective with a low rate of minor complications.

背景:这项回顾性多中心研究旨在报告采用经皮直接穿刺方法用胶水(氰基丙烯酸正丁酯)栓塞假性动脉瘤的技术安全性和有效性:从五个中心收集了 54 例患者的数据。所有患者在治疗时均表现为未破裂的 PA,且血流动力学稳定。排除了真性动脉瘤和用胶水以外的栓子治疗的病变。假性动脉瘤的诊断基于 CT 和肛门检查数据;所有病例均通过数字减影动脉造影术进行初步检查;然后在血管室(超声、透视、ConeBeam CT 引导)或 CT 中进行经皮栓塞。技术上的成功是指在最终成像时,仅采用经皮栓塞策略就能完全栓塞假性动脉瘤,而无需进行额外的血管内栓塞。临床成功是指假性动脉瘤在随访一周内消退,临床状况稳定或恢复。假性动脉瘤起源于外伤(57.4%)、炎症(24.1%)或自发性(18.5%);39 名患者(72.2%)有症状,表现为疼痛和/或搏动性肿块。平均病变直径为 19.3 毫米(范围:7-30);假性动脉瘤位于腹部(48.1%)、四肢(42.6%)和胸部(9.3%)。16.6%的患者凝血功能受损,48.1%的患者正在接受抗血小板/抗凝治疗。16.6%的患者在之前的治疗失败后采用了经皮方法。经皮穿刺的图像引导方式多为超声结合透视(38%)。所有患者都取得了临床成功,94.4%的患者取得了技术成功,因为有3名患者需要进行额外的血管内栓塞治疗。并发症发生率为14.8%,均为低度并发症,既没有临床后遗症,也没有延长康复时间(7例非靶栓塞,1例栓塞后综合征):在这项研究中,通过经皮直接穿刺用胶水栓塞假性动脉瘤安全有效,轻微并发症发生率低。
{"title":"Pseudoaneurysms embolization with glue via percutaneous direct puncture: a multicenter experience on 54 patients.","authors":"Francesco Giurazza, Annamaria Ierardi, Paolo Marra, Pierleone Lucatelli, Fabio Corvino, Francesco Pane, Sandro Sironi, Gianpaolo Carrafiello, Romaric Loffroy, Raffaella Niola","doi":"10.1186/s42155-024-00426-w","DOIUrl":"10.1186/s42155-024-00426-w","url":null,"abstract":"<p><strong>Background: </strong>This retrospective multicentric study aims to report on technical safety and effectiveness of pseudoaneurysms embolization with glue (N-butyl cyanoacrylate) adopting a percutaneous direct puncture approach.</p><p><strong>Results: </strong>Fifty-four patients data were collected from five centers. All patients at the time of treatment presented with unruptured PAs and were hemodynamically stable. True aneurysms and lesions treated with embolics other than glue were excluded. Pseudoaneurysms diagnosis was based on CT and anamnestic data; initial investigation with digital-subtracted arteriography was acquired in all cases; then, percutaneous embolizations were performed in the angio-suite (ultrasound, fluoroscopy, ConeBeam CT guidance) or in CT. Technical success was considered as complete pseudoaneurysm embolization at final imaging with sole percutaneous strategy, without need for additional endovascular embolization. Clinical success was intended as pseudoaneurysm resolution within one week follow-up with stabilization or restored clinical conditions. Pseudoaneurysms origins were traumatic (57.4%), inflammatory (24.1%) or spontaneous (18.5%); 39 patients (72.2%) were symptomatic, presenting with pain and/or pulsatile mass. Mean lesions diameter was 19.3 mm (range: 7-30); pseudoaneurysms were located in abdomen (48.1%), limbs (42.6%) and thorax (9.3%). Coagulation function was impaired in 16.6% and 48.1% was under antiplatelets/anticoagulation therapy. In 16.6% the percutaneous approach followed previous treatments failure. The image-guidance modality for percutaneous puncture was most often ultrasound combined with fluoroscopy (38%). Clinical success was obtained in all patients while technical success occurred in 94.4% because 3 patients required an additional endovascular embolization. Complications were registered in 14.8%, all of low grade without clinical sequelae neither prolonged recovery (7 non target embolizations, 1 post-embolization syndrome).</p><p><strong>Conclusions: </strong>In this study, pseudoaneurysms embolization with glue via percutaneous direct puncture was safe and effective with a low rate of minor complications.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"11"},"PeriodicalIF":1.2,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139465527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency guidewire-facilitated recanalization of chronic thoracic central venous occlusions in hemodialysis patients. 血液透析患者慢性胸腔中心静脉闭塞的射频导丝再通术。
IF 1.2 Pub Date : 2024-01-12 DOI: 10.1186/s42155-023-00422-6
Sherif Moawad, Ansar Z Vance, Ryan M Cobb, Mark P Mantell, Raphael Cohen, Timothy W I Clark

Purpose: To assess the outcome and safety of radiofrequency (RF) wire recanalization in patients with end-stage renal disease (ESRD) and chronic central venous occlusions (CVO).

Materials and methods: A retrospective review of ESRD patients who underwent RF-wire recanalization of symptomatic chronic thoracic CVO from January 2017 to August 2022 yielded 20 patients who underwent 21 procedures. All patients had undergone at least one prior unsuccessful attempt at central venous recanalization using conventional catheter-based techniques. Technical success was defined by the ability to cross the CVO using RF-wire recanalization enabling endovascular treatment. Access circuit patency was evaluated based on follow-up imaging and symptomatic improvement.

Results: Radiofrequency wire recanalization was successful in 17/21 procedures (81%) with all patients (100%) reporting resolution of arm ± facial swelling. Three major complications occurred (14%): two hemothoraces and one hemopericardium. Medial stent diameter was 13 mm (range, 9-14 mm). Mean duration of hospital stay was 2 days ± 3 days. Mean procedure time was 158 ± 46 min with a mean fluoroscopy time of 31.7 ± 16.3 min. Primary unassisted patency at 6 and 12 months was 94 ± 6% and 85 ± 10%, respectively. Additional interventions resulted in significantly increased stent graft patency (P = 0.006).

Conclusion: Radiofrequency wire-enabled recanalization of CVO in symptomatic dialysis patients has a high rate of technical success with resolution of arm and facial swelling and resumed use of the ipsilateral dialysis access. Although a superior safety profile was seen than with needle-based techniques such as sharp recanalization, major complications were not infrequent indicating that this RF-wire procedure should be performed in centers equipped to manage central venous perforations.

目的:评估终末期肾病(ESRD)和慢性中心静脉闭塞(CVO)患者接受射频(RF)导线再通术的结果和安全性:对2017年1月至2022年8月期间接受症状性慢性胸腔中心静脉闭塞射频导丝再通术的ESRD患者进行回顾性审查,结果发现20名患者接受了21次手术。所有患者之前都至少接受过一次使用传统导管技术进行中心静脉再通术的失败尝试。技术成功的定义是能够使用射频导丝再通术穿越 CVO,实现血管内治疗。根据随访成像和症状改善情况评估通路通畅情况:结果:17/21 例手术(81%)成功进行了射频导丝再通术,所有患者(100%)均报告手臂和面部肿胀得到缓解。出现了三种主要并发症(14%):两种血胸和一种血心包。内侧支架直径为 13 毫米(范围为 9-14 毫米)。平均住院时间为 2 天 ± 3 天。平均手术时间为 158 ± 46 分钟,平均透视时间为 31.7 ± 16.3 分钟。6个月和12个月的初次无辅助通畅率分别为94±6%和85±10%。额外的介入治疗使支架移植物的通畅率明显增加(P = 0.006):结论:对有症状的透析患者进行射频导丝辅助 CVO 再封堵术的技术成功率很高,可消除手臂和面部肿胀,恢复同侧透析通路的使用。虽然与锐性再通等针式技术相比,射频导丝再通术的安全性更高,但重大并发症并不少见,这表明射频导丝再通术应在具备处理中心静脉穿孔能力的中心进行。
{"title":"Radiofrequency guidewire-facilitated recanalization of chronic thoracic central venous occlusions in hemodialysis patients.","authors":"Sherif Moawad, Ansar Z Vance, Ryan M Cobb, Mark P Mantell, Raphael Cohen, Timothy W I Clark","doi":"10.1186/s42155-023-00422-6","DOIUrl":"10.1186/s42155-023-00422-6","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the outcome and safety of radiofrequency (RF) wire recanalization in patients with end-stage renal disease (ESRD) and chronic central venous occlusions (CVO).</p><p><strong>Materials and methods: </strong>A retrospective review of ESRD patients who underwent RF-wire recanalization of symptomatic chronic thoracic CVO from January 2017 to August 2022 yielded 20 patients who underwent 21 procedures. All patients had undergone at least one prior unsuccessful attempt at central venous recanalization using conventional catheter-based techniques. Technical success was defined by the ability to cross the CVO using RF-wire recanalization enabling endovascular treatment. Access circuit patency was evaluated based on follow-up imaging and symptomatic improvement.</p><p><strong>Results: </strong>Radiofrequency wire recanalization was successful in 17/21 procedures (81%) with all patients (100%) reporting resolution of arm ± facial swelling. Three major complications occurred (14%): two hemothoraces and one hemopericardium. Medial stent diameter was 13 mm (range, 9-14 mm). Mean duration of hospital stay was 2 days ± 3 days. Mean procedure time was 158 ± 46 min with a mean fluoroscopy time of 31.7 ± 16.3 min. Primary unassisted patency at 6 and 12 months was 94 ± 6% and 85 ± 10%, respectively. Additional interventions resulted in significantly increased stent graft patency (P = 0.006).</p><p><strong>Conclusion: </strong>Radiofrequency wire-enabled recanalization of CVO in symptomatic dialysis patients has a high rate of technical success with resolution of arm and facial swelling and resumed use of the ipsilateral dialysis access. Although a superior safety profile was seen than with needle-based techniques such as sharp recanalization, major complications were not infrequent indicating that this RF-wire procedure should be performed in centers equipped to manage central venous perforations.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"10"},"PeriodicalIF":1.2,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10786812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covered stent assisted coil embolization of large Buhler aneurysm in setting of chronic celiac trunk occlusion. 覆盖支架辅助线圈栓塞慢性腹腔干闭塞的大型布勒动脉瘤。
IF 1.2 Pub Date : 2024-01-10 DOI: 10.1186/s42155-023-00416-4
Pietro Quaretti, Riccardo Corti, Antonio Mauro D'Agostino, Antonio Bozzani, Lorenzo Paolo Moramarco, Nicola Cionfoli

Background: The arc of Bühler (AOB) is a residual embryonal anastomosis between the celiac artery (CA) and the superior mesenteric artery (SMA). Although usually asymptomatic, it has clinical relevance when compensatory reverse flow between the SMA and the CA in response to celiac artery obstruction leads to aneurysm formation and bleeding. Endovascular coiling is the mainstay therapy because of the deep AOB retropancreatic location, which hinders open surgery.

Case presentation: We herein report a case of a 2.8-cm AOB saccular aneurysm and LAM compression of celiac trunk in a 47-year-old man during rehabilitation following motorcycle trauma and vertebral surgery. The patient was considered unsuitable for surgery. Neither conventional coiling nor bare-metal stent and balloon-assisted techniques for coiling were suitable because of the wide necked saccular shape of AOB aneurysm interposed between the SMA and the floor of celiac trunk. To exclude the aneurysm from direct SMA inflow and permit safe and efficient coiling to rule out retrograde sac perfusion, a 9-mm polytetrafluoroethylene stent graft (Viabahn; Gore, Phoenix, AZ, USA) was positioned in the mesenteric artery, followed by antegrade periprosthetic high-density packed coiling of the aneurysm. The AOB remained excluded from mesenteric perfusion. The patient's clinical condition and abdominal contrast-enhanced multislice computed tomographic findings were unremarkable at the 9-year follow-up.

Conclusion: The 9 year long-term efficacy in our case raises the possibility that perigraft coiling following stent-graft deployment in the SMA may represent a valuable technical option for large Bühler aneurysms that are not amenable to stand-alone coiling.

背景:布勒弧(AOB)是腹腔动脉(CA)和肠系膜上动脉(SMA)之间残留的胚胎吻合口。虽然通常无症状,但当腹腔动脉阻塞导致 SMA 和 CA 之间出现代偿性逆流,从而导致动脉瘤形成和出血时,它就具有临床意义。由于腹腔动脉瘤位于胰腺后深部,阻碍了开放手术,因此血管内旋转是主要的治疗方法:我们在此报告了一例 47 岁男性在摩托车外伤和脊椎手术后的康复过程中出现 2.8 厘米 AOB 囊状动脉瘤和腹腔干 LAM 压迫的病例。患者被认为不适合手术。由于 AOB 动脉瘤呈宽颈囊状,位于 SMA 和腹腔干底部之间,因此不适合采用传统的卷曲或裸金属支架和球囊辅助技术进行卷曲。为了将动脉瘤与 SMA 的直接流入排除在外,并进行安全有效的卷曲以排除逆行囊灌注,在肠系膜动脉中放置了一个 9 毫米的聚四氟乙烯支架移植物(Viabahn;戈尔公司,美国亚利桑那州凤凰城),然后对动脉瘤进行前向假体周围高密度填塞卷曲。AOB 仍被排除在肠系膜灌注之外。9 年随访期间,患者的临床状况和腹部对比增强多层计算机断层扫描结果均无异常:我们的病例经过 9 年的长期疗效证明,在 SMA 中部署支架移植物后进行移植物周围卷曲可能是治疗无法单独卷曲的大型布勒动脉瘤的一种有价值的技术选择。
{"title":"Covered stent assisted coil embolization of large Buhler aneurysm in setting of chronic celiac trunk occlusion.","authors":"Pietro Quaretti, Riccardo Corti, Antonio Mauro D'Agostino, Antonio Bozzani, Lorenzo Paolo Moramarco, Nicola Cionfoli","doi":"10.1186/s42155-023-00416-4","DOIUrl":"10.1186/s42155-023-00416-4","url":null,"abstract":"<p><strong>Background: </strong>The arc of Bühler (AOB) is a residual embryonal anastomosis between the celiac artery (CA) and the superior mesenteric artery (SMA). Although usually asymptomatic, it has clinical relevance when compensatory reverse flow between the SMA and the CA in response to celiac artery obstruction leads to aneurysm formation and bleeding. Endovascular coiling is the mainstay therapy because of the deep AOB retropancreatic location, which hinders open surgery.</p><p><strong>Case presentation: </strong>We herein report a case of a 2.8-cm AOB saccular aneurysm and LAM compression of celiac trunk in a 47-year-old man during rehabilitation following motorcycle trauma and vertebral surgery. The patient was considered unsuitable for surgery. Neither conventional coiling nor bare-metal stent and balloon-assisted techniques for coiling were suitable because of the wide necked saccular shape of AOB aneurysm interposed between the SMA and the floor of celiac trunk. To exclude the aneurysm from direct SMA inflow and permit safe and efficient coiling to rule out retrograde sac perfusion, a 9-mm polytetrafluoroethylene stent graft (Viabahn; Gore, Phoenix, AZ, USA) was positioned in the mesenteric artery, followed by antegrade periprosthetic high-density packed coiling of the aneurysm. The AOB remained excluded from mesenteric perfusion. The patient's clinical condition and abdominal contrast-enhanced multislice computed tomographic findings were unremarkable at the 9-year follow-up.</p><p><strong>Conclusion: </strong>The 9 year long-term efficacy in our case raises the possibility that perigraft coiling following stent-graft deployment in the SMA may represent a valuable technical option for large Bühler aneurysms that are not amenable to stand-alone coiling.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"9"},"PeriodicalIF":1.2,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10781915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139405933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning from medical errors. 从医疗事故中吸取教训。
IF 1.2 Pub Date : 2024-01-10 DOI: 10.1186/s42155-023-00406-6
Joseph J Gemmete
{"title":"Learning from medical errors.","authors":"Joseph J Gemmete","doi":"10.1186/s42155-023-00406-6","DOIUrl":"10.1186/s42155-023-00406-6","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"8"},"PeriodicalIF":1.2,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10781906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139405185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shunt dysfunction patterns after transjugular intrahepatic portosystemic shunt creation using a combination of a generic stent-graft and bare-stents. 使用通用支架移植物和裸支架组合创建经颈静脉肝内门体分流术后的分流功能障碍模式。
IF 1.2 Pub Date : 2024-01-10 DOI: 10.1186/s42155-023-00421-7
Guillaume Gravel, Florent Artru, Miriam Gonzalez-Quevedo, Georgia Tsoumakidou, Nicolas Villard, Rafael Duran, Alban Denys

Purpose: Even though transjugular intrahepatic portosystemic shunt (TIPS) using Fluency Stent-grafts provides good shunt patency rates, shunt dysfunction is a great concern after TIPS creation, occurring in up to 20% of cases within one year. The objective of this study was to describe shunt dysfunction patterns after TIPS creation using a combination of generic stent-grafts/bare-stents.

Materials and methods: Single-center retrospective study of all TIPS revisions between January 2005 and December 2020. TIPS revision angiograms were analyzed for stents' positions, stenoses' diameters, and stenoses' locations.

Results: Out of 99 TIPS, a total of 33 TIPS revisions were included. The median time to TIPS revision was 10.4 months. Angiograms showed four patterns of TIPS dysfunction-associated features (DAF), defined as follows: Type 1 was defined as stenosis located after the stent end in the hepatic vein (HV), type 2 as intra-stent stenosis located in the hepatic vein, type 3 as intra-stent stenosis or a kink in the parenchymal tract or the portal vein end of the TIPS, and type 4 as a complete TIPS occlusion. Types 1, 2, 3, and 4 were seen in 23 (69.7%), 5 (15.2%), 2 (6.1%), and 3 (9.1%) TIPS respectively. TIPS revision was successful in 30 (90.1%) patients with median pre- and post-TIPS revision PSG of 18.5 mmHg and 8 mmHg respectively (p < .001).

Conclusion: Our results illustrate the four angiographic patterns of TIPS DAF after TIPS creation using a combination of generic stent-grafts/bare-stents and emphasize the need for appropriate stent length extending to the HV/inferior vena cava junction.

目的:尽管使用 Fluency 支架移植物的经颈静脉肝内门体系统分流术(TIPS)具有良好的分流通畅率,但 TIPS 术后分流功能障碍仍是一个非常令人担忧的问题,高达 20% 的病例会在一年内出现分流功能障碍。本研究的目的是描述使用普通支架移植物/裸支架组合进行 TIPS 术后分流功能障碍的模式:单中心回顾性研究:2005 年 1 月至 2020 年 12 月期间的所有 TIPS 翻修术。对TIPS翻修血管造影的支架位置、狭窄直径和狭窄位置进行分析:结果:在99例TIPS中,共纳入了33例TIPS修补术。TIPS修复的中位时间为10.4个月。血管造影显示出四种 TIPS 功能障碍相关特征(DAF)模式,定义如下:1 型定义为位于肝静脉 (HV) 支架末端后的狭窄,2 型定义为位于肝静脉的支架内狭窄,3 型定义为支架内狭窄或 TIPS 实质束或门静脉末端的扭结,4 型定义为 TIPS 完全闭塞。1、2、3 和 4 型分别出现在 23 例(69.7%)、5 例(15.2%)、2 例(6.1%)和 3 例(9.1%)TIPS 中。30 例(90.1%)患者的 TIPS 修 复成功,TIPS 修 复前和修 复后 PSG 的中位数分别为 18.5 mmHg 和 8 mmHg(p 结论:我们的研究结果说明了使用普通支架移植物/裸支架组合创建 TIPS 后 TIPS DAF 的四种血管造影模式,并强调了将支架长度适当延伸至 HV/下腔静脉交界处的必要性。
{"title":"Shunt dysfunction patterns after transjugular intrahepatic portosystemic shunt creation using a combination of a generic stent-graft and bare-stents.","authors":"Guillaume Gravel, Florent Artru, Miriam Gonzalez-Quevedo, Georgia Tsoumakidou, Nicolas Villard, Rafael Duran, Alban Denys","doi":"10.1186/s42155-023-00421-7","DOIUrl":"10.1186/s42155-023-00421-7","url":null,"abstract":"<p><strong>Purpose: </strong>Even though transjugular intrahepatic portosystemic shunt (TIPS) using Fluency Stent-grafts provides good shunt patency rates, shunt dysfunction is a great concern after TIPS creation, occurring in up to 20% of cases within one year. The objective of this study was to describe shunt dysfunction patterns after TIPS creation using a combination of generic stent-grafts/bare-stents.</p><p><strong>Materials and methods: </strong>Single-center retrospective study of all TIPS revisions between January 2005 and December 2020. TIPS revision angiograms were analyzed for stents' positions, stenoses' diameters, and stenoses' locations.</p><p><strong>Results: </strong>Out of 99 TIPS, a total of 33 TIPS revisions were included. The median time to TIPS revision was 10.4 months. Angiograms showed four patterns of TIPS dysfunction-associated features (DAF), defined as follows: Type 1 was defined as stenosis located after the stent end in the hepatic vein (HV), type 2 as intra-stent stenosis located in the hepatic vein, type 3 as intra-stent stenosis or a kink in the parenchymal tract or the portal vein end of the TIPS, and type 4 as a complete TIPS occlusion. Types 1, 2, 3, and 4 were seen in 23 (69.7%), 5 (15.2%), 2 (6.1%), and 3 (9.1%) TIPS respectively. TIPS revision was successful in 30 (90.1%) patients with median pre- and post-TIPS revision PSG of 18.5 mmHg and 8 mmHg respectively (p < .001).</p><p><strong>Conclusion: </strong>Our results illustrate the four angiographic patterns of TIPS DAF after TIPS creation using a combination of generic stent-grafts/bare-stents and emphasize the need for appropriate stent length extending to the HV/inferior vena cava junction.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"7"},"PeriodicalIF":1.2,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10781922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139405186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is it a complication or a consequence - a new perspective on adverse outcomes in Interventional Radiology. 是并发症还是后果--介入放射学不良后果的新视角。
IF 1.2 Pub Date : 2024-01-05 DOI: 10.1186/s42155-023-00417-3
Anna Maria Ierardi, Velio Ascenti, Carolina Lanza, Serena Carriero, Gaetano Amato, Giuseppe Pellegrino, Francesco Giurazza, Pierluca Torcia, Gianpaolo Carrafiello

The aim of the article is to introduce a new term in post-procedural events related to the procedure itself. All the Societies and Councils report these events as complications and they are divided in mild, moderate and severe or immediate and delayed.On the other hand the term error is known as the application of a wrong plan, or strategy to achieve a goal.For the first time, we are trying to introduce the term "consequence"; assuming that the procedure is the only available and the best fit to clinical indication, a consequence should be seen as an expected and unavoidable occurrence of an "adverse event" despite correct technical execution.

本文的目的是在与手术本身相关的术后事件中引入一个新术语。我们首次尝试引入 "后果 "一词;假定手术是唯一可用且最符合临床适应症的方法,后果应被视为一种预期的、不可避免的 "不良事件",尽管技术执行正确。
{"title":"Is it a complication or a consequence - a new perspective on adverse outcomes in Interventional Radiology.","authors":"Anna Maria Ierardi, Velio Ascenti, Carolina Lanza, Serena Carriero, Gaetano Amato, Giuseppe Pellegrino, Francesco Giurazza, Pierluca Torcia, Gianpaolo Carrafiello","doi":"10.1186/s42155-023-00417-3","DOIUrl":"10.1186/s42155-023-00417-3","url":null,"abstract":"<p><p>The aim of the article is to introduce a new term in post-procedural events related to the procedure itself. All the Societies and Councils report these events as complications and they are divided in mild, moderate and severe or immediate and delayed.On the other hand the term error is known as the application of a wrong plan, or strategy to achieve a goal.For the first time, we are trying to introduce the term \"consequence\"; assuming that the procedure is the only available and the best fit to clinical indication, a consequence should be seen as an expected and unavoidable occurrence of an \"adverse event\" despite correct technical execution.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"6"},"PeriodicalIF":1.2,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10769947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139099217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
CVIR Endovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1